Skip to Content

TAK ALG-12.5 (Nesina 12.5 mg)

Generic Name: alogliptin

Pill with imprint TAK ALG-12.5 is Yellow, Elliptical / Oval and has been identified as Nesina 12.5 mg. It is supplied by Takeda Pharmaceuticals America, Inc..

Nesina is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Nesina 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TAK ALG-12.5

Nesina

Generic Name:
alogliptin
Imprint:
TAK ALG-12.5
Strength:
12.5 mg
Color:
Yellow
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dipeptidyl peptidase 4 inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Takeda Pharmaceuticals America, Inc.
National Drug Code (NDC):
64764-0125

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide